Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medexus Pharmaceuticals Inc T.MDP

Alternate Symbol(s):  MEDXF

Medexus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a North American commercial platform. The Company has a portfolio of rare disease treatment solutions. Its focus is on the therapeutic areas of oncology, hematology, rheumatology, autoimmune diseases, allergy, and dermatology. It operates through two segments: Medexus Pharma Canada and Medexus Pharma USA. Its... see more

TSX:MDP - Post Discussion

View:
Post by oceaneleven on Feb 22, 2021 3:28pm

just think

what would happen to the shorts(200k) with this tiny float if ..........just sayin & not sprayin......
Comment by GoldenArm on Feb 22, 2021 4:53pm
Looking forward to hearing the good Nasdaq news. In the past (december) another company announced they would be listed at the end of the month and the next day the stock went down a bit as people sold on news. After that the stock ticked up and on the day off, opened higher but didn't shoot through the roof. It fell into a trading range. Like MDP, the float was small less than 20M.
Comment by oceaneleven on Feb 22, 2021 5:56pm
Uddin and Ma pointed to strong sales over the first three quarter of 2020 for MDP’s US business (showing a 76-per-cent year-over-year growth) and its Canadian business (showing 14 per cent growth. The analysts noted that MDP is working on a label expansion for Ixinity in the US, while in Canada it is working toward a full launch of imaging agent Gleolan and looking to receive Health Canada ...more  
Comment by Rockafellow on Feb 24, 2021 1:24pm
Ocean, Tim Uddin donated $1million US to USF research university today to support IPF lung problems in covid patients... A Canadian company AGN is onto this with their Idenfendil drug... ... ., Check out AGN, I have a bundle of shares in this one ....
Comment by oceaneleven on Feb 24, 2021 2:15pm
i know I am tuff woman but honestly, I can only stomach 1 biopharma stock LOL!!! and that's this one... 
Comment by Rockafellow on Feb 24, 2021 3:11pm
whither thou goest, I will go.... ...  .. ...  Looking good sofar....
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities